arrow
T

Tahaniyat Lalani

uniformed services university of the health sciences
H指数:37
被引数:4,685

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enterotoxigenic Escherichia coli hyperimmune bovine colostrum for preventing travellers’ diarrhoea (TD): a randomised, double-blind, placebo-controlled trial

产肠毒素大肠杆菌高免疫牛初乳预防旅行者腹泻(TD):一项随机、双盲、安慰剂对照试验

2026-10-060
OAAI
Influenza-like illness in cigarette smokers and electronic-cigarette users: a secondary analysis from the PAIVED study

流感样疾病在吸烟者和电子烟使用者中的比较:PAIVED研究的二次分析

2026-04-170
OAAI
Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines

比较由禽蛋和细胞培养来源的流感疫苗引发的神经氨酸酶抑制抗体反应

VACCINE
IF3.5
2025-02-011
OAAI
Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism Risk
2024-09-230
OA
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification
2024-09-020
OAAI
Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae

精确的症状表型可确定不同新型冠状病毒肺炎后遗症的早期临床和蛋白质组学预测指标

2024-06-252
OAAI
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States
2023-12-063
OAAI
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort Study

队列研究中SARS-CoV-2感染后自我报告的身体健康下降和疫苗增强剂的影响

2023-11-171
OAAI
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19
2022-12-286
OAAI
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial
2022-12-014
OA
Understanding Hybrid Immunity: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines

了解杂交免疫: 对新型冠状病毒感染 (SARS-CoV-2) 和冠状病毒病2019 (新型冠状病毒肺炎) 疫苗的体液免疫反应的比较和预测

2022-07-0539
OA
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health
2022-06-075
OAAI
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies
2022-05-1871
OAAI
Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States
2022-01-2410
OAAI